OncoVista Innovative Therapies (OncoVista Innovative Therapies) Days Sales Outstanding : 0.00 (As of Sep. 2015)

View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies Days Sales Outstanding?

OncoVista Innovative Therapies's average Accounts Receivable for the three months ended in Sep. 2015 was $0.00 Mil. OncoVista Innovative Therapies's Revenue for the three months ended in Sep. 2015 was $0.00 Mil.

The historical rank and industry rank for OncoVista Innovative Therapies's Days Sales Outstanding or its related term are showing as below:

OVIT's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.665
* Ranked among companies with meaningful Days Sales Outstanding only.

OncoVista Innovative Therapies's Days Sales Outstanding stayed the same from Sep. 2014 (0.00) to Sep. 2015 (0.00).

OncoVista Innovative Therapies Days Sales Outstanding Historical Data

The historical data trend for OncoVista Innovative Therapies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies Days Sales Outstanding Chart

OncoVista Innovative Therapies Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Days Sales Outstanding

Get a 7-Day Free Trial

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of OncoVista Innovative Therapies's Days Sales Outstanding

For the Biotechnology subindustry, OncoVista Innovative Therapies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Days Sales Outstanding falls into.

OncoVista Innovative Therapies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

OncoVista Innovative Therapies's Days Sales Outstanding for the fiscal year that ended in Dec. 2014 is calculated as

	Days Sales Outstanding (A: Dec. 2014 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2013 )	+	Accounts Receivable (A: Dec. 2014 ))	/	count )	/	Revenue (A: Dec. 2014 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

OncoVista Innovative Therapies's Days Sales Outstanding for the quarter that ended in Sep. 2015 is calculated as:

	Days Sales Outstanding (Q: Sep. 2015 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2015 )	+	Accounts Receivable (A: Sep. 2015 ))	/	count )	/	Revenue (A: Sep. 2015 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

OncoVista Innovative Therapies (OTCPK:OVIT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

OncoVista Innovative Therapies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245

Website

http://www.oncovista.com

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

Executives

Alexander Ruckdaeschel	director	123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal	director	C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp	10 percent owner	777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd	10 percent owner	411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Headlines

No Headlines